The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Journal
Overview
publication venue for
-
Human immunodeficiency virus infection and left ventricular assist devices: a case series.
2011
-
Off-pump exchange of short-term percutaneous ventricular assist device (VAD) to long-term implantable VAD in severe coagulopathy and multi-organ failure.
2008
-
Recurrent device thrombi during mechanical circulatory support with an axial-flow pump is a treatable condition and does not preclude successful long-term support.
2007
-
Heart rhythm considerations in heart transplant candidates and considerations for ventricular assist devices: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006.
2006
-
International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation.
2006
-
Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol.
2005
-
Placement of a left ventricular assist device in a patient with dextrocardia.
2005
-
Assessment of myocardial recovery in a patient with acute myocarditis supported with a left ventricular assist device: a case report.
2003
-
Primary anti-phospholipid antibody syndrome caused by isolated anti-phosphatidylethanolamine antibodies presenting as cryptogenic fibrosing alveolitis with recurrent pulmonary hemorrhage after single-lung transplantation.
2002
-
Use of a donor heart that had undergone previous cardiac surgery for ASD closure.
2002
-
Prosthetic abdominal fascial closure after ventricular assist device insertion.
1995
-
Primary cardiac lymphoma treated with orthotopic heart transplantation: a case report.
1994
-
Use of a Doppler pulmonary artery catheter for continuous measurement of right ventricular pump function and contractility during single lung transplantation.
1993
-
Pulsatility and flow patterns across macro- and microcirculatory arteries of continuous-flow left ventricular assist device patients.
2023
-
Fifth bivalent omicron BA.4/BA.5 vaccination neutralization of SARS-CoV-2 in heart transplant recipients.
2023
-
Correlation between aortic valve protein levels and vector flow mapping of wall shear stress and oscillatory shear index in patients supported with continuous-flow left ventricular assist devices..
42.
2022
-
Bridging to transplant with HeartMate 3 left ventricular assist devices in the new heart organ allocation system: An individualized approach..
42.
2022
-
Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR)..
41.
2022
-
Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients - implications for the omicron variant..
41.
2022
-
Twenty-four-hour blood pressure and heart rate variability are reduced in patients on left ventricular assist device support..
41.
2022
-
Heart transplantation outcomes in cardiac sarcoidosis..
41.
2021
-
Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience..
41.
2021
-
Transcriptomic heterogeneity of antibody mediated rejection after heart transplant with or without donor specific antibodies..
40.
2021
-
Cerebral vasoreactivity in HeartMate 3 patients..
40.
2021
-
BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response..
40.
2021
-
Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study..
40.
2021
-
Safety of reduced anti-thrombotic strategy in patients with HeartMate 3 left ventricular assist device..
40.
2021
-
Consequences of functional mitral regurgitation and atrial fibrillation in patients with left ventricular assist devices..
39.
2020
-
Donor thyroid hormone therapy and heart transplantation outcomes: ISHLT transplant registry analysis..
39.
2020
-
Cardiac transplantation for cancer involving the heart..
39.
2020
-
Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial..
39.
2020
-
Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant..
39.
2020
-
Impact of race on survival in pulmonary arterial hypertension: Results from the REVEAL registry..
39.
2020
-
Association between recipient blood type and heart transplantation outcomes in the United States..
39.
2020
-
T follicular helper and memory cell responses and the mTOR pathway in murine heart transplantation..
39.
2019
-
Prognostic value of vasoactive-inotropic score following continuous flow left ventricular assist device implantation..
38.
2019
-
Prognostic implications of serial outpatient blood pressure measurements in patients with an axial continuous-flow left ventricular assist device..
38.
2018
-
Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices..
37.
2018
-
Aortic root thrombosis in patients supported with continuous-flow left ventricular assist devices..
37.
2018
-
Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock..
37.
2018
-
Limited usefulness of endoscopic evaluation in patients with continuous-flow left ventricular assist devices and gastrointestinal bleeding..
37.
2017
-
Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial..
37.
2017
-
Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients..
37.
2017
-
The ratio of circulating regulatory cluster of differentiation 4 T cells to endothelial progenitor cells predicts clinically significant acute rejection after heart transplantation..
37.
2017
-
Prevalence of polyreactive innate clones among graft--infiltrating B cells in human cardiac allograft vasculopathy..
37.
2017
-
Dose-dependent association between amiodarone and severe primary graft dysfunction in orthotopic heart transplantation..
36.
2017
-
Ventricular assist device elicits serum natural IgG that correlates with the development of primary graft dysfunction following heart transplantation..
36.
2017
-
Coculturing with endothelial cells promotes in vitro maturation and electrical coupling of human embryonic stem cell-derived cardiomyocytes..
36.
2017
-
Improved outcomes from extracorporeal membrane oxygenation versus ventricular assist device temporary support of primary graft dysfunction in heart transplant..
36.
2016
-
The role of implantable cardioverter defibrillators in patients bridged to transplantation with a continuous-flow left ventricular assist device: A propensity score matched analysis..
36.
2016
-
Discriminatory performance of positive urine hemoglobin for detection of significant hemolysis in patients with continuous-flow left ventricular assist devices..
36.
2016
-
Macrophage/monocyte-specific deletion of Ras homolog gene family member A (RhoA) downregulates fractalkine receptor and inhibits chronic rejection of mouse cardiac allografts..
36.
2016
-
Predictive value of biomarkers of hepatic fibrosis in adult Fontan patients..
36.
2016
-
Infectious complications after cardiac transplantation in patients bridged with mechanical circulatory support devices versus medical therapy..
35.
2016
-
Outcomes after stroke complicating left ventricular assist device..
35.
2016
-
National trends and outcomes in device-related thromboembolic complications and malfunction among heart transplant candidates supported with continuous-flow left ventricular assist devices in the United States..
35.
2016
-
Association of periarterial neovascularization with progression of cardiac allograft vasculopathy and long-term clinical outcomes in heart transplant recipients..
35.
2016
-
Vascular inflammation and abnormal aortic histomorphometry in patients after pulsatile- and continuous-flow left ventricular assist device placement..
35.
2016
-
Familial dilated cardiomyopathy diagnosis is commonly overlooked at the time of transplant listing..
35.
2015
-
Impact of pre-operative coronary artery disease on cardiovascular events following lung transplantation..
35.
2015
-
Incidence and predictors of myocardial recovery on long-term left ventricular assist device support: Results from the United Network for Organ Sharing database..
34.
2015
-
Continuous-flow left ventricular assist devices and usefulness of a standardized strategy to reduce drive-line infections..
35.
2015
-
Early post-operative ventricular arrhythmias in patients with continuous-flow left ventricular assist devices..
34.
2015
-
Incidence and clinical significance of late right heart failure during continuous-flow left ventricular assist device support..
34.
2015
-
Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction..
34.
2014
-
Late right heart failure during support with continuous-flow left ventricular assist devices adversely affects post-transplant outcome..
34.
2014
-
Mechanical circulatory support as a bridge to cardiac retransplantation: a single center experience..
34.
2014
-
Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support..
34.
2014
-
Prior hematologic conditions carry a high morbidity and mortality in patients supported with continuous-flow left ventricular assist devices..
33.
2014
-
Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement..
33.
2014
-
Advanced heart failure in patients infected with human immunodeficiency virus: is there equal access to care?.
33.
2014
-
Atrial arrhythmias after lung transplant: underlying mechanisms, risk factors, and prognosis..
33.
2014
-
Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: application of the HeartMate II risk score..
33.
2014
-
Post-transplant survival estimation using pre-operative albumin levels..
33.
2014
-
A simplified echocardiographic technique for detecting continuous-flow left ventricular assist device malfunction due to pump thrombosis..
33.
2014
-
Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon..
33.
2013
-
Continuous-flow left ventricular assist device exchange: clinical outcomes..
33.
2013
-
Outcome of unplanned right ventricular assist device support for severe right heart failure after implantable left ventricular assist device insertion..
33.
2013
-
Increased right-to-left ventricle diameter ratio is a strong predictor of right ventricular failure after left ventricular assist device..
32.
2013
-
Pre-operative echocardiographic features associated with persistent mitral regurgitation after left ventricular assist device implantation..
32.
2013
-
Antithrombotic strategies in children receiving long-term Berlin Heart EXCOR ventricular assist device therapy..
32.
2013
-
Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantation..
32.
2013
-
Prevalence and timing of bend relief disconnection in patients supported by the late version HeartMate II left ventricular assist device..
32.
2013
-
Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era..
32.
2013
-
The CentriMag ventricular assist device in acute heart failure refractory to medical management..
31.
2012
-
Usefulness of routine surveillance endomyocardial biopsy 6 months after heart transplantation..
31.
2012
-
Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system..
31.
2012
-
Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction..
31.
2012
-
Bridging cardiogenic shock patients with short-term ventricular support at a community hospital to long-term ventricular support at a tertiary hospital..
31.
2012
-
Markers of extracellular matrix turnover and the development of right ventricular failure after ventricular assist device implantation in patients with advanced heart failure..
31.
2011
-
Relationship of right- and left-sided filling pressures in patients with advanced heart failure: a 14-year multi-institutional analysis..
31.
2011
-
Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device..
31.
2011
-
Heart transplantation and long-term mechanical support in Japan: progress at last..
30.
2011
-
Allochimeric molecules and mechanisms in abrogation of cardiac allograft rejection..
31.
2011
-
Tolerance induction by hematopoietic cell transplantation: combined use of stem cells and progenitor cells..
30.
2011
-
Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification..
30.
2010
-
New-onset graft dysfunction after heart transplantation--incidence and mechanism-related outcomes..
30.
2010
-
Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices..
29.
2010
-
Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy..
29.
2010
-
Mediastinal radiation and adverse outcomes after heart transplantation..
29.
2009
-
Higher rate of comorbidities after cardiac retransplantation contributes to decreased survival..
28.
2009
-
Reversal of secondary pulmonary hypertension by axial and pulsatile mechanical circulatory support..
29.
2009
-
Neurocognitive assessments in advanced heart failure patients receiving continuous-flow left ventricular assist devices..
28.
2009
-
Heart transplantation in human immunodeficiency virus-positive patients..
28.
2009
-
Effect of left ventricular assist device infection on post-transplant outcomes..
28.
2009
-
C3d and C4d deposition early after lung transplantation..
27.
2008
-
Increased expression of stem cell factor and its receptor after left ventricular assist device support: a potential novel target for therapeutic interventions in heart failure..
27.
2008
-
Long-term outcomes of cardiac transplantation for peri-partum cardiomyopathy: a multiinstitutional analysis..
26.
2007
-
Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling..
26.
2006
-
Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support..
25.
2006
-
Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device..
25.
2006
-
Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure..
25.
2005
-
Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery..
25.
2005
-
Reduced myocardial blood flow during left ventricular assist device support: a possible cause of premature bypass graft closure..
24.
2005
-
Effect of diabetes on short- and long-term outcomes after left ventricular assist device implantation..
24.
2005
-
Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes..
24.
2005
-
Biventricular assist device-induced right ventricular reverse structural and functional remodeling..
24.
2005
-
A decade experience of cardiac retransplantation in adult recipients..
24.
2005
-
Myocardial restoration with embryonic stem cell bioartificial tissue transplantation..
24.
2005
-
Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: a comparative analysis with pulsatile-type devices..
24.
2005
-
Heart transplant and left ventricular assist device costs..
24.
2005
-
Simvastatin decreases myocardial tumor necrosis factor alpha content in heart transplant recipients..
24.
2005
-
Infection in permanent circulatory support: experience from the REMATCH trial..
23.
2004
-
Effects of changes in UNOS policy regarding left ventricular assist devices..
23.
2004
-
Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure..
23.
2004
-
In vitro characterization of aortic retrograde and antegrade flow from pulsatile and non-pulsatile ventricular assist devices..
23.
2004
-
Evidence of improved right ventricular structure after LVAD support in patients with end-stage cardiomyopathy..
23.
2004
-
Mechanical support for the failing cardiac allograft: a single-center experience..
22.
2003
-
Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation..
22.
2003
-
Coronary risk stratification in patients with end-stage lung disease..
21.
2002
-
Influence of graft ischemic time on outcomes following lung transplantation..
20.
2001
-
Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support..
20.
2001
-
Intravenous immunoglobulin therapy in highly sensitized cardiac allograft recipients facilitates transplantation across donor specific IGG positive cross matches..
20.
2001
-
Older recipient age is associated with reduced alloreactivity and graft rejection after cardiac transplantation..
20.
2001
-
Relationship between coronary function by positron emission tomography and temporal changes in morphology by intravascular ultrasound (IVUS) in transplant recipients..
18.
1999
-
Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients..
17.
1998
-
Methotrexate for lung transplant recipients with steroid-resistant acute rejection..
15.
1996
-
Enhanced nitric oxide production induced by the administration of L-arginine does not inhibit arterial neointimal formation after overwhelming alloimmune injury..
15.
1996
-
Cardiac function after orthotopic heart transplantation: response to postural changes, exercise, and beta-adrenergic blockade..
13.
1994
-
What are the implications of cardiac infection with cytomegalovirus before heart transplantation?.
13.
1994
-
Magnetic resonance imaging for assessment of tissue rejection after heterotopic heart transplantation..
12.
1993
-
Coronary angiography after heart transplantation: should perioperative study be the "gold standard"?.
11.
1992
-
Effects of terminal cardioplegia with leukocyte-depleted blood on heart grafts preserved for 24 hours..
11.
1992
-
The relationship of soluble interleukin-2 receptor levels to allograft arteriopathy after heart transplantation..
11.
1992
-
Canine heart-lung transplantation after twenty-four-hour hypothermic preservation with Belzer-UW solution..
10.
1991
-
Elevated soluble interleukin-2 receptor levels early after heart transplantation and long-term survival and development of coronary arteriopathy..
10.
1991
-
COVID-19 leading to acute encephalopathy in a patient with heart transplant.
2020
-
Non-invasive measurement of peripheral, central and 24-hour blood pressure in patients with continuous-flow left ventricular assist device.
2017
-
Heart transplantation of Middle Eastern patients in the United States: A brief report from the UNOS database.
2015
-
Repetitive HeartMate II pump stoppage induced by transitioning from battery to main power source: the short-to-shield phenomenon.
2014
-
Myocardial infarction after left ventricular assist device implantation: clinical course, role of aortic root thrombus, and outcomes.
2013
-
From extracorporeal membrane oxygenation to ventricular assist device oxygenation without sternotomy.
2013
-
Survival after lung transplant for coal workers' pneumoconiosis.
2012
-
Characterization of a cardiac mass using a systematic multimodality imaging approach.
2010
-
Heart transplant recipient completes ironman triathlon 22 years after surgery.
2009
-
Development of a murine ventricular assist device transcutaneous drive-line model.
2008
-
Successful management of asystole with an isolated left ventricular assist device.
2006
-
A mouse aortic patch model for mechanical circulatory support.
2005
-
Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.
2007
-
ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery..
41.
2022
-
A tale of the twist in the outflow graft: An analysis from the MOMENTUM 3 trial..
37.
2018
-
American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support.
2020
-
Cerebrovascular disease in the era of left ventricular assist devices with continuous flow: risk factors, diagnosis, and treatment.
2014
-
World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult--a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation.
2012
-
Which patient, which pump?
2003
-
Skeletal muscle dysfunction in lung transplantation.
2000